688056 莱伯泰科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.6534.9634.6973.2895.533
总资产报酬率 ROA (%)1.4464.2723.9942.8044.814
投入资产回报率 ROIC (%)1.5634.6184.3153.0375.193

边际利润分析
销售毛利率 (%)46.05445.30245.54143.79147.709
营业利润率 (%)7.33511.56010.3176.84314.447
息税前利润/营业总收入 (%)6.40310.6109.5576.05613.769
净利润/营业总收入 (%)7.04210.0729.2336.62612.570

收益指标分析
经营活动净收益/利润总额(%)102.38683.105101.67895.04991.008
价值变动净收益/利润总额(%)14.4079.74611.10112.89410.298
营业外收支净额/利润总额(%)1.018-0.525-0.024-0.108-0.184

偿债能力分析
流动比率 (X)7.2616.3265.7425.3775.958
速动比率 (X)5.5374.8674.4674.2424.760
资产负债率 (%)11.68913.37714.45215.44814.025
带息债务/全部投入资本 (%)4.3005.7387.1597.8466.193
股东权益/带息债务 (%)2,215.8171,634.4861,289.7511,165.1681,506.360
股东权益/负债合计 (%)755.534647.529591.925547.333613.024
利息保障倍数 (X)-6.355-11.929-12.615-7.775-21.166

营运能力分析
应收账款周转天数 (天)58.65948.89145.81545.23448.089
存货周转天数 (天)311.842284.693264.144249.917249.236